Literature DB >> 2836756

U50,488: a kappa-selective agent with poor affinity for mu1 opiate binding sites.

J A Clark1, G W Pasternak.   

Abstract

Although a number of potent kappa ligands have been reported, virtually all also label mu receptors with very high affinity. In contrast, we found that U50,488 is highly selective for kappa sites (Ki 12 nM) when compared to both morphine-selective (mu2) or delta receptors (both Ki values greater than 500 nM) confirming earlier reports. However, these reports did not examine interactions with mu1 receptors. In marked distinction to all other kappa-active agents examined which typically compete mu1 binding with Ki values under 1 nM, U50,488 competed mu1 binding quite poorly (Ki 370 nM). Thus, U50,488 is a highly selective kappa agent with very poor affinity for both subtypes of mu and delta receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836756     DOI: 10.1016/0028-3908(88)90052-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  13 in total

1.  Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.

Authors:  Marcello Solinas; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

2.  Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.

Authors:  Le-sha Zhang; Jun Wang; Jian-chun Chen; Yi-min Tao; Yu-hua Wang; Xue-jun Xu; Jie Chen; Yun-gen Xu; Tao Xi; Xiao-wu Hu; Yu-jun Wang; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2015-03-30       Impact factor: 6.150

3.  Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females.

Authors:  Cindee F Robles; Marissa Z McMackin; Katharine L Campi; Ian E Doig; Elizabeth Y Takahashi; Michael C Pride; Brian C Trainor
Journal:  Behav Brain Res       Date:  2014-01-18       Impact factor: 3.332

4.  Abuse Liability, Anti-Nociceptive, and Discriminative Stimulus Properties of IBNtxA.

Authors:  Ariful Islam; Mohammad Atiqur Rahman; Megan B Brenner; Allamar Moore; Alyssa Kellmyer; Harley M Buechler; Frank DiGiorgio; Vincent R Verchio; Laura McCracken; Mousumi Sumi; Robert Hartley; Joseph R Lizza; Gustavo Moura-Letts; Bradford D Fischer; Thomas M Keck
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-27

5.  Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration.

Authors:  William M Doyon; Elaina C Howard; Toni S Shippenberg; Rueben A Gonzales
Journal:  Neuropharmacology       Date:  2006-06-15       Impact factor: 5.250

6.  A cell-based, high-throughput homogeneous time-resolved fluorescence assay for the screening of potential κ-opioid receptor agonists.

Authors:  Yue Wang; Ming Yan; Guang-Yao Zheng; Ling He; Huan Yang
Journal:  Acta Pharmacol Sin       Date:  2014-06-16       Impact factor: 6.150

7.  Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.

Authors:  J A Russell; J E Coombes; G Leng; R J Bicknell
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

8.  Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats.

Authors:  K M Pumford; J A Russell; G Leng
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

9.  Effects of the kappa-opioid agonist U50,488 on parturition in rats.

Authors:  A J Douglas; G Clarke; S J MacMillan; P M Bull; I Neumann; S A Way; D M Wright; B G McGrory; J A Russell
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

10.  Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.

Authors:  M Ohno; T Yamamoto; S Ueki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.